Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1808 1
1813 1
1819 1
1821 1
1823 1
1833 1
1838 1
1894 1
1906 1
1908 1
1910 2
1913 1
1914 1
1915 1
1917 2
1924 1
1931 2
1933 1
1944 1
1945 1
1946 5
1947 1
1948 4
1949 2
1951 2
1952 3
1953 3
1954 5
1955 7
1956 9
1957 5
1958 7
1959 3
1960 3
1961 2
1962 7
1963 2
1964 15
1965 17
1966 11
1967 16
1968 15
1969 16
1970 11
1971 10
1972 22
1973 22
1974 14
1975 22
1976 18
1977 21
1978 23
1979 22
1980 20
1981 31
1982 36
1983 28
1984 38
1985 15
1986 24
1987 39
1988 39
1989 33
1990 42
1991 51
1992 52
1993 52
1994 53
1995 44
1996 54
1997 56
1998 59
1999 62
2000 59
2001 54
2002 41
2003 63
2004 63
2005 81
2006 77
2007 66
2008 92
2009 61
2010 91
2011 120
2012 98
2013 126
2014 130
2015 156
2016 153
2017 164
2018 162
2019 168
2020 186
2021 189
2022 208
2023 194
2024 151
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,795 results

Results by year

Filters applied: . Clear all
Page 1
Wearables and the medical revolution.
Dunn J, Runge R, Snyder M. Dunn J, et al. Per Med. 2018 Sep;15(5):429-448. doi: 10.2217/pme-2018-0044. Epub 2018 Sep 27. Per Med. 2018. PMID: 30259801 Review.
Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders.
Paller A, Jaworski JC, Simpson EL, Boguniewicz M, Russell JJ, Block JK, Tofte S, Dunn JD, Feldman SR, Clark AR, Schwartz G, Eichenfield LF. Paller A, et al. Among authors: dunn jd. Am J Clin Dermatol. 2018 Dec;19(6):821-838. doi: 10.1007/s40257-018-0383-4. Am J Clin Dermatol. 2018. PMID: 30168085 Review.
High-frequency actionable pathogenic exome variants in an average-risk cohort.
Rego S, Dagan-Rosenfeld O, Zhou W, Sailani MR, Limcaoco P, Colbert E, Avina M, Wheeler J, Craig C, Salins D, Röst HL, Dunn J, McLaughlin T, Steinmetz LM, Bernstein JA, Snyder MP. Rego S, et al. Among authors: dunn j. Cold Spring Harb Mol Case Stud. 2018 Dec 17;4(6):a003178. doi: 10.1101/mcs.a003178. Print 2018 Dec. Cold Spring Harb Mol Case Stud. 2018. PMID: 30487145 Free PMC article.
Whither melanoma in Australia?
Smithers BM, Dunn J, Soyer HP. Smithers BM, et al. Among authors: dunn j. Med J Aust. 2017 Oct 16;207(8):330-331. doi: 10.5694/mja17.00740. Med J Aust. 2017. PMID: 29020902 No abstract available.
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.
Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, Harper PG, Dunn J, Tudur-Smith C, West J, Falk S, Crellin A, Adab F, Thompson J, Leonard P, Ostrowski J, Eatock M, Scheithauer W, Herrmann R, Neoptolemos JP. Cunningham D, et al. Among authors: dunn j. J Clin Oncol. 2009 Nov 20;27(33):5513-8. doi: 10.1200/JCO.2009.24.2446. Epub 2009 Oct 26. J Clin Oncol. 2009. PMID: 19858379 Clinical Trial.
Intestinal Bioengineering.
Dunn JCY. Dunn JCY. Clin Transpl. 2016;32:1-4. Clin Transpl. 2016. PMID: 28564517
Editorial note: Peckham versus Newton.
Bobak M, Dunn JR. Bobak M, et al. Among authors: dunn jr. J Epidemiol Community Health. 2017 Apr;71(4):317. doi: 10.1136/jech-2016-208773. Epub 2017 Jan 16. J Epidemiol Community Health. 2017. PMID: 28093450 No abstract available.
Personal Omics for Precision Health.
Kellogg RA, Dunn J, Snyder MP. Kellogg RA, et al. Among authors: dunn j. Circ Res. 2018 Apr 27;122(9):1169-1171. doi: 10.1161/CIRCRESAHA.117.310909. Circ Res. 2018. PMID: 29700064 Review. No abstract available.
PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
Mehanna H, McConkey CC, Rahman JK, Wong WL, Smith AF, Nutting C, Hartley AG, Hall P, Hulme C, Patel DK, Zeidler SV, Robinson M, Sanghera B, Fresco L, Dunn JA. Mehanna H, et al. Among authors: dunn ja. Health Technol Assess. 2017 Apr;21(17):1-122. doi: 10.3310/hta21170. Health Technol Assess. 2017. PMID: 28409743 Free PMC article. Clinical Trial.
Reply to the letter.
Ilyas H, Mikhaeel NG, Dunn JT, Rahman F, Møller H, Smith D, Barrington SF. Ilyas H, et al. Among authors: dunn jt. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1834-1835. doi: 10.1007/s00259-018-4050-z. Eur J Nucl Med Mol Imaging. 2018. PMID: 29850928 No abstract available.
3,795 results